Current Cardiac Patients News and Events | Page 2

Current Cardiac Patients News and Events, Cardiac Patients News Articles.
Sort By: Most Relevant | Most Viewed
Page 2 of 25 | 1000 Results
Assessment of neutrophil extracellular traps in coronary thrombus of case series of patients with COVID-19
Severe COVID-19 is characterized by the intense formation of neutrophil extracellular traps (NETs), leading to the blockage of microvessels, as shown in pulmonary samples. The occurrence of ST-elevated myocardial infarction (STEMI) is a serious cardiac manifestation of COVID-19; the intrinsic mechanism of coronary thrombosis appears to still be unknown. This case series report of five patients sought to determine the role of NETs in coronary thrombosis in patients with COVID-19. (2020-12-29)

Scientists find out how nutrition affects the recovery of patients after cardiac surgery
Scientists from St Petersburg University have found out how eating habits of patients affect their recovery after cardiac surgery. People with valvular heart disease have appeared to be at risk. (2020-12-25)

Chest pain risk assessment may reduce treatment disparities
The use of a standardized tool for assessing the risk of serious outcomes in patients with chest pain was associated with women at high risk receiving comparable care to men, according to new research published in the Annals of Emergency Medicine. Care received by women at low and intermediate risk was consistent with current clinical recommendations. Men received more stress testing and were more likely to be hospitalized than women. (2020-12-23)

Controlling cardiac waves with light to better understand abnormally rapid heart rhythms
Over 300,000 people die each year in the US due to sudden cardiac death. In many cases, sudden cardiac death is caused by abnormally rapid heart rhythms called tachycardias, which means the heart cannot pump adequate blood to the body. In Chaos, researchers use mice to study tachycardias and find there are intrinsic mechanisms that exist in heart tissue that they hypothesize lead to the self-termination of rapid cardiac rhythm. (2020-12-22)

Breathing rate predicts therapeutic benefits for heart patients
Conditions causing arrhythmia are among the most common cardiac conditions. A study headed by Prof. Georg Schmidt of the Technical University of Munich (TUM) has demonstrated for the first time that the nocturnal respiratory rate can help with an important prediction: It is an indicator of whether a defibrillator will help to extend the life of patients with arrhythmia. (2020-12-21)

Socioeconomic background linked to survival after having a cardiac arrest in hospital
Hospital in-patients from lower socioeconomic backgrounds are less likely to receive prompt cardiopulmonary resuscitation (CPR) after their hearts stop beating and less likely to survive than patients from higher socioeconomic backgrounds. These are the findings of a new study in over 24,000 patients in Sweden, published in the European Heart Journal. (2020-12-20)

COVID-19: avoiding hospital caused heart disease death rise
Lower rates of hospital attendance for urgent heart problems during the initial phase of the COVID-19 pandemic may have contributed to avoidable deaths in England, finds a new study led by UCL researchers. (2020-12-20)

Study highlights stark inequality in survival after cardiac surgery between paying and NHS patients
A new study has revealed paying patients are 20 per cent less likely to die or develop major complications, such as reintervention or stroke, after cardiac surgery than NHS patients - findings researchers say cannot be explained by socioeconomic factors alone. (2020-12-16)

FARI publishes new research on omega-3s and heart rate recovery
The Fatty Acid Research Institute (FARI) has published a new research paper in conjunction with The Cooper Institute on omega-3s and heart rate recovery. Omega-3 fatty acids have a long history of being ''heart healthy'' but exactly why and how has been less clear. So how do the omega-3 fatty acids EPA and DHA work? A recent study from the Cooper Center Longitudinal Study (CCLS) and FARI sheds new light on this question. (2020-12-14)

Study shows women less likely to survive out-of-hospital cardiac arrest than men
DALLAS - Dec. 15, 2020 - A study of patients resuscitated from out-of-hospital cardiac arrest shows that women have a lower likelihood of survival compared with men and are less likely to receive procedures commonly administered following cardiac arrest. (2020-12-14)

Patients with non-cardiac chest pain are reassured with brief education
Patients diagnosed with non-cardiac chest pain are reluctant to believe they do not have heart disease. A new study shows that explaining the test results convinces patients and reduces the likelihood of future chest pain. The research is presented at EACVI - Best of Imaging 2020, a scientific congress of the European Society of Cardiology (ESC). Chest pain is one of the most frequent causes of consults at the emergency department. (2020-12-12)

Test your heart health by climbing stairs
Climbing four flights of stairs in less than a minute indicates good heart health, according to research presented at EACVI - Best of Imaging 2020, a scientific congress of the European Society of Cardiology (ESC). 'The stairs test is an easy way to check your heart health,' said study author Dr. Jesús Peteiro, a cardiologist at University Hospital A Coruña, Spain. (2020-12-11)

Flavors added to vaping devices can damage the heart
The appealing array of fruit and candy flavors that entice millions of young people take up vaping can harm their hearts, a preclinical study by University of South Florida Health (USF Health) researchers found. The team investigated in cardiac cells and in young mice the potential cardiotoxic effects of the many flavoring chemicals added to the e-liquids in electronic nicotine delivery systems. (2020-12-11)

Insufficient screening for heart damage after noncardiac surgery puts patients at risk
About five percent of patients experience heart muscle injury around the time of their surgery for a noncardiac condition, yet guideline recommendations to identify patients at risk using biomarkers are not being followed. A five-year study in Alberta, Canada appearing in the Canadian Journal of Cardiology, published by Elsevier, determined that the recommended biomarker screening is very much underutilized. (2020-12-10)

Predicting heart disease from the skin
Jefferson researchers find that the genetic underpinnings of a skin disorder at birth indicate future heart problems. (2020-12-10)

Time to lower body temperature is critical in out-of-hospital cardiac arrest
Time to reach the target body temperature was a significant factor in achieving favorable neurological outcomes in patients with witnessed out-of-hospital cardiac arrest. Significantly more favorable neurological outcomes occurred if the time to target temperature management was <600 min or less. (2020-12-09)

Octapharma presents research on congenital & acquired bleeding disorders at ASH Meeting
Octapharma USA will present multiple clinical research posters focused on the efficacy and safety of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for Intravenous Use in the treatment of congenital and acquired bleeding disorders during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, a virtual medical congress to be held December 5 - 8, 2020. (2020-12-03)

COVID-19 advice may have reduced exposure to heart attack triggers
A new study suggests that COVID-19 guidance in Sweden may have reduced people's risks of having a heart attack. By using anonymous location data from mobile phones, researchers developed an aggregate picture of the activities of the Swedish population and mapped it against attendances at the country's 29 emergency cardiac angiography units. (2020-12-03)

Researchers uncover significant reason older adults are at greater risk of heart attack
A team of surgeons has found an insufficient level of the protein Sesn2 is the reason older individuals are at greater risk of heart attack, which indicates stabilizing the protein could be the answer to maintaining a healthy heart. (2020-12-03)

New activity found for CHD7, a protein factor vital in embryonic development
Research has yielded fundamental insights into the causes of severe birth defects known as CHARGE syndrome cases. These congenital birth defects include severe and life-threatening heart malformations. Researchers successfully inactivated the gene for CHD7 in the neural crest cells of mouse embryos, and then rigorously probed how this change in developing cardiac neural crest cells caused severe defects in the outflow tract and great arteries, leading to perinatal lethality. (2020-12-02)

Statins can save lives, are they being used?
People who have coronary artery disease, stroke or peripheral artery disease often are prescribed a statin, a cholesterol-lowering drug that reduces the risk of heart attack or stroke. (2020-12-01)

Scoring system improves screening for "dual" heart disease
Aortic stenosis is one of the most common heart valve defects. As well as conventional valve replacement involving open-heart surgery, a less invasive procedure has now been available for some time in the form of transcatheter aortic valve replacement (TAVR). (2020-11-24)

Closing the racial disparity gap in survival after in-hospital cardiac arrest
In-hospital cardiac arrests (IHCA) represent catastrophic and often terminal events. Despite investments to improve the quality of resuscitation efforts, fewer than 25% of all patients that experience cardiac arrests in hospitals survive to discharge, and survival varies significantly across hospitals and by race. Until now, few have been able to specify reasons for the between-hospital differences. (2020-11-24)

COVID-19 patients survive in-hospital cardiac arrest at pre-pandemic rates
Resuscitation and survival rates of hospitalized COVID-19 patients who've had cardiac arrest are much higher than earlier reports of near-zero; variation at the individual hospital level may have affected overall numbers (2020-11-20)

A bypass route for the coronary vessels in the heart?
When the heart develops, some of its coronary blood vessels develop from cells lining the inner surface of the heart's ventricular chambers (endocardium). Novel findings suggest that new blood vessel growth in the heart can be stimulated with the VEGF-B growth factor from the same source after myocardial infarction to increase blood delivery to the damaged area. (2020-11-19)

A novel drug target for neonatal and infant heart failure
Researchers have identified a new druggable target for heart failure in neonates and infants. Approximately 60 percent of children born with congenital heart abnormalities will develop overt heart failure within the first year of life. The progression of heart failure in these infants is often rapid, with a high frequency of fatalities. Stimulation of this target significantly increased the cardiac contractility of newborns and infants in mice with few side effects. (2020-11-19)

Implantation of an S-ICD in a patient with a DDD pacemaker and congenitally corrected transposition
Implantation of an S-ICD in a Patient with a DDD Pacemaker and Congenitally Corrected Transposition of the Great Arteries. In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0597, Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, Beijing, China consider implantation of an S-ICD in a patient with a DDD pacemaker and congenitally corrected transposition of the great arteries. (2020-11-19)

Mediastinal tuberculoma mimicking malignant cardiac tumor
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0587, Yiqian Ding, Wei Li, Yanqiu Liu, Min Ye, Liangping Cheng, Donghong Liu, Hong Lin and Fengjuan Yao from The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China consider mediastinal tuberculoma mimicking malignant cardiac tumors. (2020-11-19)

3D bioprinted heart provides new tool for surgeons
Surgeons will soon have a powerful new tool for planning and practice with the creation of the first full-sized 3D bioprinted model of the human heart. (2020-11-18)

Early details of brain damage in COVID-19 patients
Looking at six patients using a specialized magnetic resonance technique, researchers at Massachusetts General Hospital found that COVID-19 patients with neurological symptoms show some of the same metabolic disturbances in the brain as other patients who have suffered oxygen deprivation from other causes, but there are also notable differences. (2020-11-18)

One-month of dual anti-platelet therapy is safe and feasible after stent placement
A short, one-month treatment combining antiplatelet medication and aspirin followed by an aspirin-only regime was as effective as a 6- to 12-month course of dual treatment at preventing death, heart attacks, strokes, bleeding or the need for additional stent placement. The results of this study could lead to changes in treatment and improve patient compliance, lower costs and fewer side effects. (2020-11-16)

Patients at risk of atrial fibrillation may need additional monitoring after heart surgery
There appears to be a high rate of unrecognized atrial fibrillation in the month following heart surgery among people who have an increased risk of stroke, even when atrial fibrillation was not detected immediately following surgery. When high-risk patients wore a heart monitor 24-hours a day for 30 days after heart surgery, atrial fibrillation was detected ten times more often than in patients who were not monitored continuously. (2020-11-16)

A change of heart -- new drug for HCM reduces heart mass
For the first time, a medication has impacted heart muscle thickness and function for patients with the most common inherited heart condition, hypertrophic cardiomyopathy, rather than simply addressing their symptoms. (2020-11-16)

STRENGTH trial finds new fish oil medication did not reduce the risk of cardiac events
A medication derived from fish oil, containing the omega-3 fatty acids EPA and DHA, was evaluated in a large, international study of more than 13,000 people who had existing heart disease or who were at high risk of heart disease due to other medical conditions. The medication did not reduce the risk of cardiac events compared to a corn oil-based placebo in the STRENGTH trial. (2020-11-15)

Omega-3s did not reduce cardiac events in recent heart attack survivors
Omega-3 supplements in commonly available forms appear to be ineffective in preventing further cardiovascular events among elderly people with recent heart attacks. When compared to a placebo, an omega-3 fatty acids supplement in addition to statin therapy and/or a blood thinner did not reduce the number of cardiac events in a study of more than 1,000 patients in Norway. (2020-11-15)

Outcomes for out-of-hospital cardiac arrest during COVID-19 pandemic
This study used a large US registry of out-of-hospital cardiac arrests to asses the association between the COVID-19 pandemic and the outcomes of out-of-hospital cardiac arrests, including in areas with low and moderate COVID-19 disease. (2020-11-14)

Additional heart imaging valuable for women with unexplained heart attacks
Combining diagnostic imaging methods can detect the underlying cause of heart attack in women who did not have blocked arteries. This international, diagnostic, prospective, observational study suggested that additional heart imaging is feasible and has the potential to guide medical therapy to prevent subsequent heart attacks. (2020-11-14)

New medicine reduced risk for heart failure emergencies, hospital visits
Results from a large, Phase 3, global, cardiovascular outcomes study indicate a new medication may reduce the risk for heart failure-related events or cardiovascular deaths in people with chronic heart failure. (2020-11-13)

Minnesota cardiac arrest resuscitation treatment demonstrated 100% success rate in cannulation
University of Minnesota Minnesota Mobile Resuscitation Consortium proves high survival rates in a peer-reviewed study. (2020-11-13)

Single institution study finds high rates of cardiac complications in MIS-C
During the height of the COVID-19 pandemic, researchers at Children's National Hospital discovered that as many as one half of children diagnosed with multisystem inflammatory disease in children (MIS-C) at the hospital developed cardiac complications including coronary artery abnormalities, even when diagnosed and treated promptly. (2020-11-13)

Page 2 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.